Back to ING GROEP NV ING GROEP NV

VRTXVRTX
29 quarters

Position history for ING GROEP NVING GROEP NV's holdings in VERTEX PHARMACEUTICALS INC

ING GROEP NV holds 223,124 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $110.8M as of 2026-Q2. The position was increased (+241.0% shares). VRTX represents 0.5% of ING GROEP NV's portfolio.

Current Value

$110.8M

Current Shares

223,124

Total Value Change

+$96.9M

Total Shares Change

+147,259

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
223,124
+241.0%
$110.8M0.5%$496.73
68
2026-Q1
Decreased
65,425
-19.4%
$29.2M0.2%$474.27
0
2025-Q4
Increased
81,129
+576.7%
$36.8M0.2%$453.74
56
2025-Q3
New
11,989
-
$4.7M0.0%$395.31
37
2025-Q1
Exited
0
-100.0%
$00.0%$492.69
0
2024-Q4
Decreased
4,784
-91.1%
$1.9M0.0%$399.35
0
2024-Q3
Decreased
53,538
-19.0%
$24.9M0.1%$462.88
0
2024-Q2
Decreased
66,125
-14.2%
$31M0.2%$468.72
0
2024-Q1
Increased
77,043
+2.6%
$32.2M0.2%$418.01
35
2023-Q4
Decreased
75,098
-11.8%
$30.6M0.2%$406.89
0
2023-Q3
Increased
85,158
+8.6%
$29.6M0.3%$347.74
37
2023-Q2
Increased
78,413
+77.0%
$27.6M0.2%$348.18
52
2023-Q1
New
44,298
-
$14M0.1%$312.16
46
2022-Q4
Exited
0
-100.0%
$00.0%$288.78
0
2022-Q3
Increased
60,025
+5.4%
$17.4M0.3%$292.80
36
2022-Q2
Increased
56,969
+409.5%
$16.1M0.2%$280.35
54
2022-Q1
Decreased
11,181
-74.6%
$2.9M0.0%$256.52
0
2021-Q4
Increased
43,987
+67.0%
$9.7M0.1%$222.45
41
2021-Q3
Increased
26,346
+2.0%
$4.8M0.1%$182.22
27
2021-Q2
Increased
25,826
+50.0%
$5.2M0.1%$196.78
37
2021-Q1
Decreased
17,212
-0.2%
$3.7M0.1%$212.99
0
2020-Q4
Increased
17,248
+199.2%
$4.1M0.1%$232.68
43
2020-Q3
Increased
5,765
+162.9%
$1.6M0.1%$270.31
41
2020-Q2
Decreased
2,193
-82.7%
$637,0000.0%$285.18
0
2020-Q1
Increased
12,700
+675.3%
$3M0.1%$231.92
51
2019-Q4
Decreased
1,638
-89.8%
$359,0000.0%$218.97
0
2019-Q3
Decreased
16,043
-79.0%
$2.7M0.1%$166.74
0
2019-Q2
Increased
76,299
+0.6%
$14M0.2%$183.38
34
2019-Q1
New
75,865
-
$14M0.3%$183.95
46

Other major holders of VRTX: BNP PARIBAS FINANCIAL MARKETS, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used